Biotech: The good times aren't over
Lower valuations make now a good buying opportunity for long-term growth in the biotech sector See acast.com/privacy for privacy and opt-out information.
Investors' Chronicle · Investors' Chronicle
September 22, 201622m 11s
Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Lower valuations make now a good buying opportunity for long-term growth in the biotech sector
Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.
Investors' Chronicle is a service by the Financial Times.
Hosted on Acast. See acast.com/privacy for more information.